Kemira Oyj (KEMIRA)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 16.20 |
|---|---|
| 52-week range | 15.29 – 21.46 |
| Return, 1 month / 3 months | −6.1% / −2.3% |
| Return, 1 year / 3 years | −9.9% / +22.5% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 23.5% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 3.26M EUR |
| Dividend yield | 7.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kemira Oyj is a Finnish chemicals company based in Helsinki that serves water-intensive industries and municipal water utilities. It makes water treatment chemicals for drinking water and wastewater, and process chemicals for the pulp and paper industry, along with products for oil, gas and mining customers. Its customers include municipalities, industrial plants and paper producers who use these chemicals to purify water, improve production and handle waste streams.
The shares are listed on the Helsinki Exchange in Finland under the code KEMIRA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kemira Oyj (KEMIRA) trades on the Helsinki Exchange in Finland. It last closed at EUR 16.20 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 69 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.9% and over the last three months it fell 2.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.3% | ||
| From 52-week high | -24.4% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.3% | ||
| 6-month return | -13.7% | ||
| 12-month return, skipping the last month | -4.1% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 3.26M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 91 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.0% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −6.1% |
| 3 months | −2.3% |
| 6 months | −13.7% |
| 1 year | −9.9% |
| 3 years | +22.5% |
| 5 years | +49.4% |
Signals
| 50-day / 200-day average | 16.91 / 17.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2026 | EUR 0.3800 |
| 20 Mar 2026 | EUR 0.3800 |
| 27 Oct 2025 | EUR 0.3700 |
| 21 Mar 2025 | EUR 0.3700 |
| 28 Oct 2024 | EUR 0.3400 |
| 21 Mar 2024 | EUR 0.3400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.